| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.27 | 1e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.22 | 4e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |